|Articles|January 1, 2015
- BioPharm International-01-01-2015
- Volume 28
- Issue 1
BioPharm International, January 2015 Issue (PDF)
Click the title above to open the BioPharm International January 2015 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 11 years ago
Great Expectations from New European Commissionabout 11 years ago
Analyzing Protein Aggregation in Biopharmaceuticalsabout 11 years ago
Raw Materials and the Development Cycleabout 11 years ago
Fill/Finish Capacity Use for Biologicsabout 11 years ago
Politics and Patients to Shape Pharma in 2015about 11 years ago
Standards Organizations Updateabout 11 years ago
Adopting the Product Lifecycle Approachabout 11 years ago
Ligand-Binding Assays and the Determination of Biosimilarityabout 11 years ago
Drug Breakthroughs, with Some Reservationsabout 11 years ago
Technologies and Practices Must Evolve to Meet DemandNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Beyond Transactional: Collaborative Partnerships for Rapid, Flexible Biologics Development
2
How FDA’s Bayesian Guidance Could Accelerate Adaptive Trial Design in Biopharmaceuticals
3
Novartis Calls for Global Governments to Address Global Trade Policy
4